Government to push up with re-assessment plan over 3,000 drugs

The government has reaffirmed that it will re-evaluate the economic effectiveness of 3,000 medicines listed in national health insurance this year without any modification, rejecting the speculation that the re-assessment schedule would be delayed in the midst of contracted business conditions.

The Ministry for Health, Welfare and Family Affairs said on January 21 that the price cut for lipi...